Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase EARLY_PHASE1 2

Status

Unknown 3Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4Observational 1Expanded_access 1

Sponsor

Cancer Type

Tumor-Agnostic 3Genitourinary 1

Conditions

Neoplasms 3Prostatic Neoplasms 1Neoplasm Metastasis 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2331Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1784Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 936Prednisone 926Cetuximab 921Lenalidomide 916Trastuzumab 902

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Gallium-68 × Clear all
NCT02391025 2023-06-18

Gallium-68 Citrate PET Used in Prostate Cancer

University of California, San Francisco

Phase EARLY_PHASE1 Completed
39 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT05490849 2023-02-22

68Ga-HX01 PET in Healthy Volunteers and Malignant Tumors Patients

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase EARLY_PHASE1 Unknown
100 enrolled
Tumor-Agnostic

Neoplasms

NCT04554719 2023-02-14

Clinical Application of Fibroblast Activation Protein PET/MRI for Diagnosis and Staging in Malignant Tumors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase NA Unknown
500 enrolled
Tumor-Agnostic

Neoplasms

NCT05006326 2023-02-14

Clinical Application of 68Ga-PSMA PET/MR for Diagnosis and Staging in Hepatocellular Carcinoma

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase NA Unknown
30 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡